Literature DB >> 12175311

Effect of irradiation fluence rate on the efficacy of photodynamic therapy and tumor oxygenation in meta-tetra (hydroxyphenyl) chlorin (mTHPC)-sensitized HT29 xenografts in nude mice.

Stéphanie Coutier1, Lina N Bezdetnaya, Thomas H Foster, Robert-Michel Parache, François Guillemin.   

Abstract

We present direct experimental evidence of the fluence-rate-dependent, radiation-induced variations in intratumor oxygen partial pressure (pO(2)) in HT29 human colon adenocarcinoma xenografts subjected to meta-tetra(hydroxyphenyl)chlorin (mTHPC)-based photodynamic therapy (PDT). The data establish a correlation between tumor oxygenation and treatment outcome. Tumor-bearing mice were injected with 0.3 mg/kg photosensitizer and subjected 72 h later to a 12 J/cm(2) red light dose administered at fluence rates of 5, 30, 90 and 160 mW/cm(2). A significant decrease in mean and median pO(2) was registered at approximately half of the total radiation fluence was delivered in tumors treated at rates of 160 and 90 mW/cm(2). Conversely, with the two lower fluence rates, intratumor pO(2) was maintained at levels comparable to those measured before illumination. Tumor oxygenation values registered shortly after every treatment protocol were at least equal to baseline levels, thus excluding the possibility of significant acute vessel damage during illumination. The tumor regrowth profile correlated with the pO(2) values monitored during irradiation. Tumors treated with fluence rates of 5 and 30 mW/cm(2) exhibited significantly longer tumor quadrupling times than those treated at 160 and 90 mW/cm(2). Improved tumor destruction could be expected by reducing the rate and the extent of oxygen depletion during meta-tetra(hydroxyphenyl)chlorin photodynamic therapy using low fluence rates.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12175311     DOI: 10.1667/0033-7587(2002)158[0339:eoifro]2.0.co;2

Source DB:  PubMed          Journal:  Radiat Res        ISSN: 0033-7587            Impact factor:   2.841


  12 in total

1.  Increasing damage to tumor blood vessels during motexafin lutetium-PDT through use of low fluence rate.

Authors:  Theresa M Busch; Hsing-Wen Wang; E Paul Wileyto; Guoqiang Yu; Ralph M Bunte
Journal:  Radiat Res       Date:  2010-09       Impact factor: 2.841

Review 2.  Photodynamic therapy and anti-tumour immunity.

Authors:  Ana P Castano; Pawel Mroz; Michael R Hamblin
Journal:  Nat Rev Cancer       Date:  2006-07       Impact factor: 60.716

3.  Photodynamic killing of Enterococcus faecalis in dentinal tubules using mTHPC incorporated in liposomes and invasomes.

Authors:  Anna Ossmann; Stefan Kranz; Guellmar Andre; Andrea Völpel; Volker Albrecht; Alfred Fahr; Bernd W Sigusch
Journal:  Clin Oral Investig       Date:  2014-06-21       Impact factor: 3.573

4.  Fluence rate-dependent intratumor heterogeneity in physiologic and cytotoxic responses to Photofrin photodynamic therapy.

Authors:  Theresa M Busch; Xiaoman Xing; Guoqiang Yu; Arjun Yodh; E Paul Wileyto; Hsing-Wen Wang; Turgut Durduran; Timothy C Zhu; Ken Kang-Hsin Wang
Journal:  Photochem Photobiol Sci       Date:  2009-10-15       Impact factor: 3.982

5.  T-cell mediated anti-tumor immunity after photodynamic therapy: why does it not always work and how can we improve it?

Authors:  Florian Anzengruber; Pinar Avci; Lucas Freitas de Freitas; Michael R Hamblin
Journal:  Photochem Photobiol Sci       Date:  2015-06-11       Impact factor: 3.982

6.  The vascular disrupting agent 5,6-dimethylxanthenone-4-acetic acid improves the antitumor efficacy and shortens treatment time associated with Photochlor-sensitized photodynamic therapy in vivo.

Authors:  Mukund Seshadri; David A Bellnier
Journal:  Photochem Photobiol       Date:  2008-07-17       Impact factor: 3.421

7.  Assessment of apoptosis by immunohistochemistry to active caspase-3, active caspase-7, or cleaved PARP in monolayer cells and spheroid and subcutaneous xenografts of human carcinoma.

Authors:  Aude Bressenot; Sophie Marchal; Lina Bezdetnaya; Julie Garrier; François Guillemin; François Plénat
Journal:  J Histochem Cytochem       Date:  2008-11-24       Impact factor: 2.479

8.  Prediction of tumor recurrence and therapy monitoring using ultrasound-guided photoacoustic imaging.

Authors:  Srivalleesha Mallidi; Kohei Watanabe; Dmitriy Timerman; David Schoenfeld; Tayyaba Hasan
Journal:  Theranostics       Date:  2015-01-01       Impact factor: 11.556

9.  Correlation of real-time haemoglobin oxygen saturation monitoring during photodynamic therapy with microvascular effects and tissue necrosis in normal rat liver.

Authors:  J H Woodhams; L Kunz; S G Bown; A J MacRobert
Journal:  Br J Cancer       Date:  2004-08-16       Impact factor: 7.640

10.  Photodynamic therapy with conventional and PEGylated liposomal formulations of mTHPC (temoporfin): comparison of treatment efficacy and distribution characteristics in vivo.

Authors:  Vadzim Reshetov; Henri-Pierre Lassalle; Aurélie François; Dominique Dumas; Sebastien Hupont; Susanna Gräfe; Vasco Filipe; Wim Jiskoot; François Guillemin; Vladimir Zorin; Lina Bezdetnaya
Journal:  Int J Nanomedicine       Date:  2013-10-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.